Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods

被引:9
|
作者
Nyberg, Sofia D. [1 ]
Meurman, Olli [2 ]
Jalava, Jari [1 ]
Rantakokko-Jalava, Kaisu [2 ]
机构
[1] Natl Publ Hlth Inst, Lab Human Microbial Ecol, Dept Bacterial & Inflammatory Dis, FIN-20520 Turku, Finland
[2] Turku Univ Hosp, Clin Microbiol Lab, FIN-20520 Turku, Finland
关键词
D O I
10.1080/00365540701704706
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 123 clinical Escherichia coli and Klebsiella spp. isolates were included in the study in order to evaluate VITEK 2 AST-N029 (Nordic) card for detection of extended-spectrum beta-lactamases (ESBL) and to compare the results with genotypic ESBL verification. The results were also compared to alternative phenotypic methods, i.e. agar dilution and disk diffusion. The strains that were ESBL-positive according to AST-N029 were further analysed with the ESBL test card, VITEK 2 AST-N041. Using genotype as reference, Vitek 2 AES had the highest accuracy of the tested methods in classifying the strains as ESBL-positive or -negative (91.1%). When VITEK 2 gave ESBL as the only option for E. coli or K. pneumoniae, 44 of 45 (97.8%) strains had an ESBL gene. VITEK 2 achieved an accuracy of 94.9% and disk diffusion 95.9% compared to the agar dilution method as the phenotypic reference method for the E. coli and K. pneumoniae strains. For the K. oxytoca strains VITEK 2 achieved the highest accuracy (84.0%) of the methods used in this work.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 50 条
  • [41] Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates
    Stürenburg, E
    Sobottka, I
    Feucht, HH
    Mack, D
    Laufs, R
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (01) : 29 - 34
  • [42] Acceptable performance of VITEK 2 system to detect extended-spectrum β-lactamases in clinical isolates of Escherichia coli:: a comparative study of phenotypic commercial methods and NCCLS guidelines
    Sorlózano, A
    Gutiérrez, J
    Piédrola, G
    Soto, MJ
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (03) : 191 - 193
  • [43] The accuracy of extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella pneumoniae in South African laboratories using the Vitek 2 Gram-negative susceptibility card AST-N255
    Young, Andrea L.
    Nicol, Mark P.
    Moodley, Clinton
    Bamford, Colleen M.
    SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2019, 34 (01)
  • [44] Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae
    Ho, PL
    Chow, KH
    Yuen, KY
    Ng, WS
    Chau, PY
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) : 49 - 54
  • [45] Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014
    Odsbu, Ingvild
    Khedkar, Smita
    Lind, Frida
    Khedkar, Uday
    Nerkar, Sandeep S.
    Orsini, Nicola
    Tamhankar, Ashok J.
    Lundborg, Cecilia Stalsby
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (01):
  • [46] Detection and Molecular Characterization of Escherichia coli Strains Producers of Extended-Spectrum and CMY-2 Type Beta-Lactamases, Isolated from Turtles in Mexico
    Cortes-Cortes, Gerardo
    Lozano-Zarain, Patricia
    Torres, Carmen
    Castaneda, Miguel
    Moreno Sanchez, Gabriela
    Alonso, Carla A.
    Lopez-Pliego, Liliana
    Gutierrez Mayen, Maria G.
    Martinez-Laguna, Ygnacio
    del Carmen Rocha-Gracia, Rosa
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2016, 16 (09) : 595 - 603
  • [47] Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime
    Jang, Woori
    Park, Yeon-Joon
    Park, Kang Gyun
    Yu, Jinkyung
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2282 - 2285
  • [48] Evaluation of the capability of the VITEK 2 system to detect extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes
    H. M. Chen
    J. J. Wu
    P. F. Tsai
    J. Y. Wann
    J. J. Yan
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 871 - 874
  • [49] Evaluation of the capability of the VITEK 2 system to detect extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes
    Chen, H. M.
    Wu, J. J.
    Tsai, P. F.
    Wann, J. Y.
    Yan, J. J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (07) : 871 - 874
  • [50] Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria
    Alheib, Omar
    Al Kayali, Rawaa
    Abajy, M. Yaser
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2015, 10 (03):